Monday, 24 July 2017

China News

  • Biobanking has attractive prospects in Asia

    China |  Opinion | By BioSpectrum Bureau | 0 Comment | 12 Jun, 2012

    Asia is becoming increasingly important as a market for upcoming biobanks. Within Asia, India, China and Japan have attractive prospects. Many countries in Asia have launched or are about t...Read more

  • CPhI China to begin from June 21

    China |  News | By BioSpectrum Bureau | 0 Comment | 10 May, 2016

    Singapore: Hosted by the UBM EMEA and CCCMHPIE and co-organised by UBM Sinoexpo, this year's CPhI China will be conducted at the Shanghai New International Exhibition Centre (SNIEC) China f...Read more

  • China Cord Blood, Cordlife join hands for stem cell therapy services

    China |  News | By BioSpectrum Bureau | 0 Comment | 25 Jul, 2014

    Singapore: China Cord Blood Corporation (CCBC) and Cordlife Group, a multi-product healthcare company catering to the mother and child segment, have come together to assist patients across ...Read more

  • China firm Beigene raises $75 mn

    China |  News | By BioSpectrum Bureau | 0 Comment | 18 Nov, 2014

    Singapore: China based biotech firm developing targeted and immune-oncology therapeutics, BeiGene, has raised $75 million from a group of investors. "We currently have three oncology candi...Read more

  • Johns Hopkins releases NCD policy briefs

    China |  Analysis | By BioSpectrum Bureau | 0 Comment | 05 Feb, 2013

    Singapore: Johns Hopkins University's Institute for Applied Economics, Global Health and the Study of Business Enterprise has released a focused set of policy briefs that provide actionable...Read more

  • Generon initiates phase I clinical study for F-652 in Australia

    China |  News | By BioSpectrum Bureau | 0 Comment | 06 Sep, 2012

    Singapore: Generon (Shanghai)has initiated phase I clinical trial for F-652 in Australia. F-652 is a recombinant protein containing a human interleukin-22 (IL-22) dimer. The current phase I...Read more

  • Type 2 diabetes could be next epidemic in India, China

    China |  Analysis | By BioSpectrum Bureau | 0 Comment | 07 Feb, 2013

    Singapore: Despite modern science's best efforts, the most common type of diabetes, Type 2, is reaching epidemic levels across the world, especially India and China, according to market ana...Read more

  • Challenge No 1: A culture cauldron

    China |  Analysis | By Narayan Kulkarni | 0 Comment | 17 May, 2012

    The countries in Asia have different languages, cultures and religion. Some of them are even a melting pot of people from different linguistic, cultural and historical backgrounds. This div...Read more

  • Aus drug delivery technology gets Chinese patent

    China |  News | By BioSpectrum Bureau | 0 Comment | 30 Apr, 2013

    Singapore: Australian drug delivery technology company Imugene has received key Chinese patent application for the company's novel drug delivery technology Linguet. The Chinese application...Read more

  • Successful Year With a Redefined Business Model

    China |  Analysis | By BioSpectrum Bureau | 0 Comment | 23 Jun, 2015

    Singapore:  SINOPHARM Group, China Chairman: Mr Wei YulinRevenue: $31299.8 mnBusiness: R&D, manufacturing, distribution of healthcare products, value added supply chain, service provi...Read more

  • China's Zai Lab raises $100mn

    China |  News | By BioSpectrum Bureau | 0 Comment | 11 Jan, 2016

    Singapore: China based Zai Lab, an innovative biopharmaceutical company, has secured over $100 million in Series B financing from a group of investors led by Advantech Capital and included ...Read more

  • China launches nationwide inspection of vaccines

    China |  News | By BioSpectrum Bureau | 0 Comment | 27 Jul, 2016

    Singapore: Ahead of a huge recent vaccine scandal racket revealing China's vaccine black market in March this year, Chinese health authorities have now appointed a special investigation tea...Read more

  • 3SBio appoints Kevin Xiao Weihong as new COO

    China |  News | By BioSpectrum Bureau | 0 Comment | 07 Mar, 2016

    Singapore: China based 3SBio has appointed Kevin Xiao Weihong as its new chief operating officer. "We are pleased to welcome Kevin to 3SBio where he will play a key role in providing lead...Read more

  • Breast cancer market will rise to $3.4 billion by 2021'

    China |  News | By BioSpectrum Bureau | 0 Comment | 16 Feb, 2016

    Singapore: The Asia-Pacific (APAC) breast cancer market is set to experience considerable expansion from $1.9 billion in 2014 to $3.4 billion by 2021, at a robust Compound Annual Growth Rat...Read more

  • Jeremy Yee quits China Cord Blood board

    China |  Influencers | By BioSpectrum Bureau | 0 Comment | 30 Sep, 2013

    Singapore: Mr Jeremy Yee, an independent non-executive director of China Cord Blood Corporation (CCBC), a provider of cord blood collection, laboratory testing, hematopoietic stem cell proc...Read more

  • China's Jiangsu Hengrui to build a new biologics facility

    China |  News | By BioSpectrum Bureau | 0 Comment | 20 Jul, 2015

    Singapore: China-based Jiangsu Hengrui Medicine recently announced plans to build a biologics manufacturing plant in Suzhou with an investment of $137 million. Hengrui, an integrated pharma...Read more

  • F&S: China, India are hotspot for cardiac imaging

    China |  Analysis | By BioSpectrum Bureau | 0 Comment | 03 Jan, 2013

    ‎Singapore: A new study from Frost & Sullivan titled 'Global Trends in Medical Imaging-Cardiology Applications', has pointed out that there has been a shift in the adoption patter...Read more

  • It's raining expansions and JVs in China!

    China |  Analysis | By Amrita Tejasvi | 0 Comment | 19 Apr, 2013

    Biopharma firms, which are located on the western part of the globe, are keeping a close watch on the dragon nation, with hopes that they can leverage on the potential that China has to off...Read more

Survey Box

Is value- based patient healthcare system more effective in Asian countries?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls